Riesgo cardiovascular en pacientes con esclerosis sistémica
Chico Capote, Araceli; Estévez del Toro, Miguel Hernán; Cruz Cárcamo, Orlando Antonio; Puente Carmona, Rolando.
Rev. cuba. med
; 632024.
Artigo em Espanhol | LILACS, CUMED | ID: biblio-1550908
Documentos relacionados
Clusters of comorbidities in fibrotic hypersensitivity pneumonitis.
Dyspepsia in children: organic or functional? Experience in a tertiary care hospital.
Ileoanal Pouch Syndrome Is Common and Associated With Significant Disability in Patients With Ulcerative Colitis Undergoing IPAA.
Development of a Polygenic Risk Score to Predict Diverticulitis.
The first Norwegian doctorate in multiple sclerosis.
A Validated Prognostic Model and Nomogram to Predict Early-Onset Complications Leading to Surgery in Patients With Crohn's Disease.
A systematic review and meta-analysis of cardiovascular diseases and associated factors among diabetes mellitus patients in Ethiopia.
Comparison of the yield of two tuberculosis screening approaches among household contacts in a community setting of Silti Zone, Central Ethiopia: a prospective cohort study.
El péptido Pro-BNP como predictor de daño cardíaco en pacientes con esclerosis sistémica
The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors.